Latest News and Press Releases
Want to stay updated on the latest news?
-
BOSTON, July 27, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the appointment of Scott A. Holmes to Chief Financial Officer effective immediately. Mr. Holmes...
-
BOSTON, July 24, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
-
BOSTON, June 24, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for people with renal disease,...
-
BOSTON, June 16, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc., (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal disease,...
-
NEW YORK, May 12, 2015 (GLOBE NEWSWIRE) -- In the press release issued on May 5, 2015 by Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) under the same headline, please note that the May 13th...
-
NEW YORK, May 5, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that Greg Madison, the Company's Chief Executive Officer, will be presenting a company overview,...
-
BOSTON and NEW YORK, May 4, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with...
-
BOSTON, April 30, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal disease...
-
BOSTON and NEW YORK, April 27, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with...
-
BOSTON and NEW YORK, April 23, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company"), today announced the appointment of John F. Neylan, MD to the newly created...